388 related articles for article (PubMed ID: 23450558)
1. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.
Owers DS; Webster AC; Strippoli GF; Kable K; Hodson EM
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD005133. PubMed ID: 23450558
[TBL] [Abstract][Full Text] [Related]
2. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.
Strippoli GF; Hodson EM; Jones CJ; Craig JC
Cochrane Database Syst Rev; 2006 Jan; (1):CD005133. PubMed ID: 16437521
[TBL] [Abstract][Full Text] [Related]
3. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Hodson EM; Ladhani M; Webster AC; Strippoli GF; Craig JC
Cochrane Database Syst Rev; 2013 Feb; (2):CD003774. PubMed ID: 23450543
[TBL] [Abstract][Full Text] [Related]
4. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Vernooij RW; Michael M; Ladhani M; Webster AC; Strippoli GF; Craig JC; Hodson EM
Cochrane Database Syst Rev; 2024 May; 5(5):CD003774. PubMed ID: 38700045
[TBL] [Abstract][Full Text] [Related]
5. Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients.
Strippoli GF; Hodson EM; Jones C; Craig JC
Transplantation; 2006 Jan; 81(2):139-45. PubMed ID: 16436954
[TBL] [Abstract][Full Text] [Related]
6. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Hodson EM; Barclay PG; Craig JC; Jones C; Kable K; Strippoli GF; Vimalachandra D; Webster AC
Cochrane Database Syst Rev; 2005 Oct; (4):CD003774. PubMed ID: 16235341
[TBL] [Abstract][Full Text] [Related]
7. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Hodson EM; Craig JC; Strippoli GF; Webster AC
Cochrane Database Syst Rev; 2008 Apr; (2):CD003774. PubMed ID: 18425894
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients.
Hodson EM; Jones CA; Strippoli GF; Webster AC; Craig JC
Cochrane Database Syst Rev; 2007 Apr; (2):CD005129. PubMed ID: 17443573
[TBL] [Abstract][Full Text] [Related]
9. WITHDRAWN: Cytomegalovirus prophylaxis with antiviral agents for solid organ transplantation.
Couchoud-Heyer C
Cochrane Database Syst Rev; 2007 Jul; 1998(4):CD001320. PubMed ID: 17636667
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients.
Kalil AC; Levitsky J; Lyden E; Stoner J; Freifeld AG
Ann Intern Med; 2005 Dec; 143(12):870-80. PubMed ID: 16365468
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Interventions for preventing thrombosis in solid organ transplant recipients.
Surianarayanan V; Hoather TJ; Tingle SJ; Thompson ER; Hanley J; Wilson CH
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD011557. PubMed ID: 33720396
[TBL] [Abstract][Full Text] [Related]
13. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials.
Hodson EM; Jones CA; Webster AC; Strippoli GF; Barclay PG; Kable K; Vimalachandra D; Craig JC
Lancet; 2005 Jun 18-24; 365(9477):2105-15. PubMed ID: 15964447
[TBL] [Abstract][Full Text] [Related]
14. New developments in the management of cytomegalovirus infection after solid organ transplantation.
Eid AJ; Razonable RR
Drugs; 2010 May; 70(8):965-81. PubMed ID: 20481654
[TBL] [Abstract][Full Text] [Related]
15. Anti-herpesvirus prophylaxis, pre-emptive treatment or no treatment in adults undergoing allogeneic transplant for haematological disease: systematic review and meta-analysis.
Beyar-Katz O; Bitterman R; Zuckerman T; Ofran Y; Yahav D; Paul M
Clin Microbiol Infect; 2020 Feb; 26(2):189-198. PubMed ID: 31536817
[TBL] [Abstract][Full Text] [Related]
16. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178
[TBL] [Abstract][Full Text] [Related]
17. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients.
Hahn D; Hodson EM; Hamiwka LA; Lee VW; Chapman JR; Craig JC; Webster AC
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004290. PubMed ID: 31840244
[TBL] [Abstract][Full Text] [Related]
18. Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.
Webster AC; Wu S; Tallapragada K; Park MY; Chapman JR; Carr SJ
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD004756. PubMed ID: 28731207
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 2 receptor antagonists for kidney transplant recipients.
Webster AC; Ruster LP; McGee R; Matheson SL; Higgins GY; Willis NS; Chapman JR; Craig JC
Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD003897. PubMed ID: 20091551
[TBL] [Abstract][Full Text] [Related]
20. Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients.
Karpe KM; Talaulikar GS; Walters GD
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD006750. PubMed ID: 28730648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
